Zendi Solano

761 total citations
21 papers, 484 citations indexed

About

Zendi Solano is a scholar working on Epidemiology, Health and Hepatology. According to data from OpenAlex, Zendi Solano has authored 21 papers receiving a total of 484 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Epidemiology, 8 papers in Health and 5 papers in Hepatology. Recurrent topics in Zendi Solano's work include Vaccine Coverage and Hesitancy (8 papers), Respiratory viral infections research (5 papers) and Hepatitis B Virus Studies (5 papers). Zendi Solano is often cited by papers focused on Vaccine Coverage and Hesitancy (8 papers), Respiratory viral infections research (5 papers) and Hepatitis B Virus Studies (5 papers). Zendi Solano collaborates with scholars based in United States, Netherlands and Italy. Zendi Solano's co-authors include Lina S. Sy, Bradley K. Ackerson, Hung Fu Tseng, Jeff Slezak, Yi Luo, Christine A. Fischetti, Vivek Shinde, Steven J. Jacobsen, Jaejin An and Katia Bruxvoort and has published in prestigious journals such as JAMA, PEDIATRICS and Clinical Infectious Diseases.

In The Last Decade

Zendi Solano

20 papers receiving 473 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Zendi Solano United States 8 426 146 138 63 46 21 484
Agron Plevneshi Canada 9 516 1.2× 145 1.0× 39 0.3× 25 0.4× 46 1.0× 13 605
Miriam Cebey‐López Spain 12 245 0.6× 185 1.3× 84 0.6× 13 0.2× 37 0.8× 25 455
Richard Nathan United States 6 526 1.2× 239 1.6× 27 0.2× 113 1.8× 119 2.6× 7 666
Avi Collins United States 3 457 1.1× 137 0.9× 30 0.2× 113 1.8× 113 2.5× 4 568
Lusiné Kostanyan United States 6 392 0.9× 184 1.3× 112 0.8× 34 0.5× 42 0.9× 9 456
Lauren E. Roper United States 11 566 1.3× 361 2.5× 184 1.3× 175 2.8× 51 1.1× 14 825
Nathalie De Schrevel Belgium 7 432 1.0× 200 1.4× 122 0.9× 32 0.5× 45 1.0× 16 497
Anna Chiara Vittucci Italy 10 230 0.5× 143 1.0× 94 0.7× 15 0.2× 13 0.3× 28 342
Monica Godfrey United States 9 226 0.5× 220 1.5× 58 0.4× 126 2.0× 23 0.5× 11 431
Bahaa Abu Raya Israel 10 402 0.9× 137 0.9× 71 0.5× 142 2.3× 48 1.0× 13 526

Countries citing papers authored by Zendi Solano

Since Specialization
Citations

This map shows the geographic impact of Zendi Solano's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Zendi Solano with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Zendi Solano more than expected).

Fields of papers citing papers by Zendi Solano

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Zendi Solano. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Zendi Solano. The network helps show where Zendi Solano may publish in the future.

Co-authorship network of co-authors of Zendi Solano

This figure shows the co-authorship network connecting the top 25 collaborators of Zendi Solano. A scholar is included among the top collaborators of Zendi Solano based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Zendi Solano. Zendi Solano is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Rayens, Emily, Lina S. Sy, Lei Qian, et al.. (2025). Effectiveness and safety of the recombinant zoster vaccine in individuals ≥50 years of age with rheumatoid arthritis: a matched cohort and self-controlled case series study. Annals of the Rheumatic Diseases. 84(6). 960–969. 1 indexed citations
2.
Slezak, Jeff, Katia Bruxvoort, Lina S. Sy, et al.. (2025). Validation of ICD‐10 Diagnosis Codes for Identification of Acute Myocardial Infarction From a US Integrated Healthcare System. Pharmacoepidemiology and Drug Safety. 34(7). e70179–e70179. 1 indexed citations
3.
Rayens, Emily, Lina S. Sy, Lei Qian, et al.. (2025). P-14. Vaccine Effectiveness and Safety of Recombinant Zoster Vaccine in Inflammatory Bowel Disease Patient Populations Aged 50 Years and Older. Open Forum Infectious Diseases. 12(Supplement_1). 1 indexed citations
4.
Bruxvoort, Katia, Lina S. Sy, Jeff Slezak, et al.. (2024). Post-marketing safety study to evaluate pregnancy outcomes among recipients of hepatitis B vaccines. Human Vaccines & Immunotherapeutics. 20(1). 2397872–2397872.
5.
Ackerson, Bradley K., Lina S. Sy, Jeff Slezak, et al.. (2023). Post-licensure safety study of new-onset immune-mediated diseases, herpes zoster, and anaphylaxis in adult recipients of HepB-CpG vaccine versus HepB-alum vaccine. Vaccine. 41(30). 4392–4401. 3 indexed citations
6.
Bruxvoort, Katia, Jeff Slezak, Lei Qian, et al.. (2022). Association Between 2-Dose vs 3-Dose Hepatitis B Vaccine and Acute Myocardial Infarction. JAMA. 327(13). 1260–1260. 14 indexed citations
7.
Bruxvoort, Katia, Bradley K. Ackerson, Lina S. Sy, et al.. (2021). Recombinant Adjuvanted Zoster Vaccine and Reduced Risk of Coronavirus Disease 2019 Diagnosis and Hospitalization in Older Adults. The Journal of Infectious Diseases. 225(11). 1915–1922. 30 indexed citations
8.
Bruxvoort, Katia, Lina S. Sy, Bradley K. Ackerson, et al.. (2021). Challenges in Phase 4 post-licensure safety studies using real world data in the United States: Hepatitis B vaccine example. Vaccine X. 8. 100101–100101. 3 indexed citations
9.
Becerra-Culqui, Tracy A., Lina S. Sy, Bradley K. Ackerson, et al.. (2020). Safety of MenACWY-CRM vaccine exposure during pregnancy. Vaccine. 38(12). 2683–2690. 5 indexed citations
10.
Becerra-Culqui, Tracy A., Lina S. Sy, Zendi Solano, & Hung Fu Tseng. (2020). Real-world evidence of quadrivalent meningococcal conjugate vaccine safety in the United States: a systematic review. Human Vaccines & Immunotherapeutics. 17(5). 1432–1441. 2 indexed citations
11.
Tseng, Hung Fu, Lina S. Sy, Bradley K. Ackerson, et al.. (2020). Severe Morbidity and Short- and Mid- to Long-term Mortality in Older Adults Hospitalized with Respiratory Syncytial Virus Infection. The Journal of Infectious Diseases. 222(8). 1298–1310. 75 indexed citations
12.
Bruxvoort, Katia, Jeff Slezak, Bradley K. Ackerson, et al.. (2020). Association of Number of Doses With Hepatitis B Vaccine Series Completion in US Adults. JAMA Network Open. 3(11). e2027577–e2027577. 24 indexed citations
13.
Ackerson, Bradley K., Jaejin An, Lina S. Sy, et al.. (2020). Cost of Hospitalization Associated With Respiratory Syncytial Virus Infection Versus Influenza Infection in Hospitalized Older Adults. The Journal of Infectious Diseases. 222(6). 962–966. 34 indexed citations
14.
Becerra-Culqui, Tracy A., Lina S. Sy, Bradley K. Ackerson, et al.. (2019). Safety of quadrivalent meningococcal conjugate vaccine in infants and toddlers 2 to 23-months old. Vaccine. 38(2). 228–234. 4 indexed citations
15.
Becerra-Culqui, Tracy A., Lina S. Sy, Bradley K. Ackerson, et al.. (2019). Safety of MenACWY-CRM vaccine exposure during pregnancy. Annals of Epidemiology. 40. 41–41. 2 indexed citations
16.
Ackerson, Bradley K., Hung Fu Tseng, Lina S. Sy, et al.. (2018). Severe Morbidity and Mortality Associated With Respiratory Syncytial Virus Versus Influenza Infection in Hospitalized Older Adults. Clinical Infectious Diseases. 69(2). 197–203. 227 indexed citations
17.
Tartof, Sara Y., Lina S. Sy, Bradley K. Ackerson, et al.. (2017). Safety of Quadrivalent Meningococcal Conjugate Vaccine in Children 2–10 Years. The Pediatric Infectious Disease Journal. 36(11). 1087–1092. 7 indexed citations
18.
Tseng, Hung Fu, Lina S. Sy, Bradley K. Ackerson, et al.. (2017). Morbidity, and Short- and Intermediate-term Mortality, in Adults ≥60 Years Hospitalized with Respiratory Syncytial Virus Infection vs. Seasonal Influenza Virus Infection. Open Forum Infectious Diseases. 4(suppl_1). S318–S319. 2 indexed citations
19.
Tseng, Hung Fu, Lina S. Sy, Bradley K. Ackerson, et al.. (2016). Safety of Quadrivalent Meningococcal Conjugate Vaccine in 11- to 21-Year-Olds. PEDIATRICS. 139(1). 18 indexed citations
20.
Sy, Lina S., In‐Lu Amy Liu, Zendi Solano, et al.. (2010). Accuracy of influenza vaccination status in a computer-based immunization tracking system of a managed care organization. Vaccine. 28(32). 5254–5259. 26 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Agron Plevneshi Breakdown of academic impact, for papers by Miriam Cebey‐López Breakdown of academic impact, for papers by Richard Nathan Breakdown of academic impact, for papers by Avi Collins Breakdown of academic impact, for papers by Lusiné Kostanyan Breakdown of academic impact, for papers by Lauren E. Roper Breakdown of academic impact, for papers by Nathalie De Schrevel Breakdown of academic impact, for papers by Anna Chiara Vittucci Breakdown of academic impact, for papers by Monica Godfrey Breakdown of academic impact, for papers by Bahaa Abu Raya
Rankless by CCL
2026